slogan: Recombinant monoclonal antibodies and membrane proteins for drug discovery.
The company's innovative offerings include the DiMPro™ Membrane Protein Platform, DimAb® Single B Cell Antibody Discovery Platform, DiLibrary™ Mammalian Display Antibody Engineering Platform, and DiAssay™ Antibody Evaluation Platform. Its last investment, an Angel Round, was in September 2019, with funding from Emerging Technology Partners, Guoqian Venture Capital, and Huatai Zijin Investment. Dima Biotechnology aims to accelerate drug discovery for the Biopharma sector, fostering innovation and expediting life-changing therapy development.
Dima Biotechnology
Recombinant monoclonal antibodies and membrane proteins for drug discovery.
Founded 2018
Rockville, United States
6 employees
Angel
Biotechnology, Health Care
Rockville, United States
6 employees
Angel
Biotechnology, Health Care
General Information
Company Name
Dima Biotechnology
Founded Year
2018
Location
Rockville, United States
Rockville, United States
Employees
6
Industries
Biotechnology, Health Care
Funding Stage
Angel
BounceWatch is an independent company data service, not affiliated with Dima Biotechnology. To contact Dima Biotechnology, visit dimabio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Dima Biotechnology compare?
A PDF of Dima Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Dima Biotechnology soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Dima Biotechnology
Business keywords: Biotech, Monoclonal Antibodies, Membrane Proteins, Drug Discovery, Preclinical R&D, Biopharma Research, Antibody Technology, Mammalian Cell Expression, GPCRs, Ion Channels, B Cell Antibody Discovery, Antibody Engineering, Screening Processes, Therapy Development, Innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Angel Round | Undisclosed | 3 |
|
11 Sep 2019 |
Dima Biotechnology Alternatives & Competitors
View All Alternatives
Dima Biotechnology vs
Pioneering novel methods for precise targeting of challenging therapeutic proteins in drug discovery...
Seed
5 employees
Biotechnology, Health Care
Dima Biotechnology vs
Design Pharmaceuticals Inc.
United States
Boundless GPCR drug discovery
Seed
3 employees
Biotechnology, Health Care
Dima Biotechnology vs
Creative Biolabs
United States
Antibody discovery, antibody engineering.
23 employees
Biotechnology, Health Care
FAQ About Dima Biotechnology
Recombinant monoclonal antibodies and membrane proteins for drug discovery.
Dima Biotechnology was founded in 2018.
Dima Biotechnology is headquartered in Rockville, United States.
Dima Biotechnology operates in Biotechnology and Health Care. Its work centres on Biotech, Monoclonal Antibodies, Membrane Proteins and Drug Discovery.
Dima Biotechnology has approximately 6 employees.
Dima Biotechnology has completed 1 funding round. The latest funding stage is Angel.
Top alternatives and competitors to Dima Biotechnology include MSM Protein Technologies, Inc., Design Pharmaceuticals Inc., Creative Biolabs, Ablexis, LLC, Novelogics Biotechnology Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dima Biotechnology and MSM Protein Technologies, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Dima Biotechnology, https://bouncewatch.com/company/dima-biotechnology, updated 24 October 2024. When citing, please name BounceWatch and link this page.
